The MTHFR A1298C polymorphism and Breast Cancer Susceptibility
MTHFR A1298C and Breast Cancer Risk
DOI:
https://doi.org/10.29409/jfgwwy82Keywords:
A1298C polymorphism, Breast cancer, Folate, MTHFR, Methylation of DNAAbstract
Background:Breast cancer (BC) is still a worldwide health problem with a high mortality rate in Iraq and other countries. reductase gene (MTHFR) controls cell DNA methylation, and any defect in this gene may lead to cancer development.
Aim: The goal of this study was to investigate the associations of SNP (rs1801131) A1298C genetic polymorphism of MTHFR gene as well as its haplotypes with breast cancer risk among Iraqi females. Materials and Methods: The study included fifty individuals diagnosed with breast cancer and fifty healthy controls. The ages of the patients ranged between 25 and 67 years. For DNA extraction, 1 ml of peripheral blood from each individual was used. The A1298C polymorphism was detected with a previously prepared kit according to the manufacturer’s instructions. Taq-Man allelic discrimination assay was used for genotype identification. Then, p values were calculated via a chi-square test for statistical analysis.
Results: DNA was successfully extracted from all the samples. The breast cancer patients and control groups all had frequency genotypes consistent with Hardy-Weinberg equilibrium (HWE) expectations. Logistic regression was used to assess the etiological risk of A1298C polymorphism in breast cancer cases. Breast cancer cases were more common in people with the heterozygous mutant AC genotype, which was significantly associated (p = 0.016; OR = 2.88; 95% CI: 1.29–6.4). The risk factor of the mutant AC genotype increased 2.88 times more than that for the wild type. Conclusions: According to the study results, there is a variation in the distribution of the genetic frequency of the MTHFR polymorphism between patients and control individuals, which is associated with increased etiological risk of the A1298C SNP (rs1801131) in breast cancer patients.
References
AL-Hashimi MMY. Trends in Breast Cancer Incidence in Iraq During the Period 2000-2019. Asian Pacific J Cancer Prev. 2021;22(12):3889-3896. doi:10.31557/APJCP.2021.22.12.3889
Lyon P, Strippoli V, Fang B, Cimmino L. B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease. Nutrients. 2020 Sep 19;12(9):2867. doi:10.3390/nu12092867
Mandaviya PR, Joehanes R, Brody J, et al. Association of dietary folate and vitamin B-12 intake with genome-wide DNA methylation in blood: a large-scale epigenome-wide association analysis in 5841 individuals. Am J Clin Nutr. 2019 Aug 1;110(2):437-450. doi:10.1093/ajcn/nqz031
Mattei, A. L., Bailly, N., & Meissner, A. DNA methylation: a historical perspective. Trends in Genetics. 2022 Jul;38(7):676-707. https://doi.org/https://doi.org/10.1016/j.tig.2022.03.010
Gurugubelli, K. R., & Ballambattu, V. B. Perspectives on folate with special reference to epigenetics and neural tube defects. Reproductive Toxicology. 2024 March; 125, 108576. https://doi.org/10.1016/j.reprotox.2024.108576
Antonaros F, Olivucci G, Cicchini E, et al. MTHFR C677T polymorphism analysis: A simple, effective restriction enzyme‐based method improving previous protocols. Mol Genet Genomic Med. 2019 February ;7:e628. https://doi.org/10.1002/ mgg3.628
Undas A, Chojnowski K, Kluskowska A, et al. Determination and interpretation of MTHFR gene mutations in gynecology and internal medicine. Pol Arch Intern Med. 2019; 129: 728‑732. doi:10.20452/pamw.15039
Petrone I, Bernardo PS, Dos Santos EC, Abdelhay E. MTHFR C677T and A1298C Polymorphisms in Breast Cancer, Gliomas and Gastric Cancer: A Review. Genes (Basel). 2021 Apr 17;12(4):587. doi:10.3390/genes12040587
Sabbah,M.A., Al-Sammarraie, H.I, Al-zubaidi,M.M,. Mahmood,H.H, Salih,K.M, Al-Mayah,Q.S., Bader,A.H . Identification and quantification of Chimerism in bone marrow transplants leukemic patients. Iraqi Journal of Cancer and Medical Genetics (IJCMG). 2017 ;10(1):41-47.
Sambrook, J. and Russel, D. Molecular cloning: a laboratory manual. 3rded. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press. 2001.
Castiglia P, Sanna V, Azara A, et al. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in breast cancer: a Sardinian preliminary case-control study. Int J Med Sci. 2019;16(8):1089-1095. 2019 Jul 22. doi:10.7150/ijms.32162
Zarembska E, Ślusarczyk K, Wrzosek M. The Implication of a Polymorphism in the Methylenetetrahydrofolate Reductase Gene in Homocysteine Metabolism and Related Civilisation Diseases. International Journal of Molecular Sciences. 2024; 25(1):193. https://doi.org/10.3390/ijms25010193
Omran, M.H.; E Fotouh, B.; Shousha, W.G.; Ismail, A.; Ibrahim, N.E.; Ramadan, S.S. Strong Correlation of MTHFR Gene Polymorphisms with Breast Cancer and its Prognostic Clinical Factors among Egyptian Females. Asian Pac. J. Cancer Prev. 2021, 22, 617–626.
Liu, W . Li ,Y. Li ,R. Han ,X. Ma ,Y. Liu ,B. Kong, X. Association of MTHFR A1298C Polymorphism with breast cancer and /or Ovarian cancer risk: an updated meta analysis. Afr J Tradit Complement Altern Med. 2016;13(5):72-86. 2016 Aug 12. doi:10.21010/ajtcam.v13i5.11
Durán, M.; Ángel, C.; Araújo, M.D.; Pinheiro, D.D.R.; Burbano, R.M.R.; Borges, B.D.N. Thymidylate synthase and methylenete trahydrofolate reductase polymorphisms and breast cancer susceptibility in a Brazilian population. Meta Gene. 2021, 28, 100889.
Sharma R, Hoskins JM, Rivory LP, et al. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients. Clin Cancer Res. 2008 Feb 1;14(3):817-25.. doi:10.1158/1078-0432.CCR-07-0425
Additional Files
Received
Revised
Accepted
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Cancer and Medical Genetics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
